Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Peptide Therapeutics Market Report for Period 2018 till 2024

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

Scope of the Report:
This report focuses on the Peptide Therapeutics in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Injection
Oral
Other

Market Segment by Applications, can be divided into
Cancer
Metabolic Disorders
Central Nervous System
Other

There are 15 Chapters to deeply display the global Peptide Therapeutics market.

Chapter 1, to describe Peptide Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Peptide Therapeutics, with sales, revenue, and price of Peptide Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Peptide Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Peptide Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Peptide Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Peptide Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Oral
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Metabolic Disorders
1.3.3 Central Nervous System
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market Status and Outlook (2013-2023)
1.4.1.2 Canada Market Status and Outlook (2013-2023)
1.4.1.3 Mexico Market Status and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market Status and Outlook (2013-2023)
1.4.2.2 France Market Status and Outlook (2013-2023)
1.4.2.3 UK Market Status and Outlook (2013-2023)
1.4.2.4 Russia Market Status and Outlook (2013-2023)
1.4.2.5 Italy Market Status and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market Status and Outlook (2013-2023)
1.4.3.2 Japan Market Status and Outlook (2013-2023)
1.4.3.3 Korea Market Status and Outlook (2013-2023)
1.4.3.4 India Market Status and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market Status and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market Status and Outlook (2013-2023)
1.4.4.2 Egypt Market Status and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market Status and Outlook (2013-2023)
1.4.4.4 South Africa Market Status and Outlook (2013-2023)
1.4.4.5 Nigeria Market Status and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Peptide Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva
2.2.1 Business Overview
2.2.2 Peptide Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novo Nordisk
2.3.1 Business Overview
2.3.2 Peptide Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Peptide Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eli Lilly
2.5.1 Business Overview
2.5.2 Peptide Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Peptide Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Peptide Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Shire
2.8.1 Business Overview
2.8.2 Peptide Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AbbVie
2.9.1 Business Overview
2.9.2 Peptide Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ipsen
2.10.1 Business Overview
2.10.2 Peptide Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Allergan
2.11.1 Business Overview
2.11.2 Peptide Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Allergan Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ferring
2.12.1 Business Overview
2.12.2 Peptide Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Ferring Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Merck
2.13.1 Business Overview
2.13.2 Peptide Therapeutics Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Merck Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 The Medicines
2.14.1 Business Overview
2.14.2 Peptide Therapeutics Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 The Medicines Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche
2.15.1 Business Overview
2.15.2 Peptide Therapeutics Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Roche Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 J & J
2.16.1 Business Overview
2.16.2 Peptide Therapeutics Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 J & J Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Peptide Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Peptide Therapeutics Manufacturer Market Share
3.3.2 Top 6 Peptide Therapeutics Manufacturer Market Share
3.4 Market Competition Trend
4 Global Peptide Therapeutics Market Analysis by Regions
4.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Peptide Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Peptide Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Peptide Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Peptide Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Peptide Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Peptide Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Peptide Therapeutics Sales and Growth Rate (2013-2018)
5 North America Peptide Therapeutics by Countries
5.1 North America Peptide Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Peptide Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Peptide Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Peptide Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Peptide Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Peptide Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Peptide Therapeutics by Countries
6.1 Europe Peptide Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Peptide Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Peptide Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Peptide Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Peptide Therapeutics by Countries
7.1 Asia-Pacific Peptide Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Peptide Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Peptide Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Peptide Therapeutics Sales and Growth Rate (2013-2018)
8 South America Peptide Therapeutics by Countries
8.1 South America Peptide Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Peptide Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Peptide Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Peptide Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Peptide Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Peptide Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Peptide Therapeutics by Countries
9.1 Middle East and Africa Peptide Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Peptide Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Peptide Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Peptide Therapeutics Sales and Growth Rate (2013-2018)
10 Global Peptide Therapeutics Market Segment by Type
10.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Peptide Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Peptide Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Injection Sales Growth and Price
10.2.1 Global Injection Sales Growth (2013-2018)
10.2.2 Global Injection Price (2013-2018)
10.3 Oral Sales Growth and Price
10.3.1 Global Oral Sales Growth (2013-2018)
10.3.2 Global Oral Price (2013-2018)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2013-2018)
10.4.2 Global Other Price (2013-2018)
11 Global Peptide Therapeutics Market Segment by Application
11.1 Global Peptide Therapeutics Sales Market Share by Application (2013-2018)
11.2 Cancer Sales Growth (2013-2018)
11.3 Metabolic Disorders Sales Growth (2013-2018)
11.4 Central Nervous System Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Peptide Therapeutics Market Forecast (2018-2023)
12.1 Global Peptide Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Peptide Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Peptide Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Peptide Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Peptide Therapeutics Market Forecast (2018-2023)
12.2.4 South America Peptide Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Peptide Therapeutics Market Forecast (2018-2023)
12.3 Peptide Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Peptide Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Peptide Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Peptide Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Peptide Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Peptide Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 38157

Category: 11

Published date: 2018-03-25 14:19:33

Number of Pages: 105

Publisher Name: GIR

Over all Rating: 96 % (Average of Ratings provided by clients)